These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9352019)

  • 21. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia.
    Reuvekamp A; Velsing-Aarts FV; Poulina IE; Capello JJ; Duits AJ
    Br J Obstet Gynaecol; 1999 Oct; 106(10):1019-22. PubMed ID: 10519425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia.
    Lyall F; Greer IA; Boswell F; Fleming R
    Br J Obstet Gynaecol; 1997 Feb; 104(2):223-8. PubMed ID: 9070144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.
    Taylor RN; Grimwood J; Taylor RS; McMaster MT; Fisher SJ; North RA
    Am J Obstet Gynecol; 2003 Jan; 188(1):177-82. PubMed ID: 12548214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microvascular permeability is related to circulating levels of tumour necrosis factor-alpha in pre-eclampsia.
    Anim-Nyame N; Gamble J; Sooranna SR; Johnson MR; Steer PJ
    Cardiovasc Res; 2003 Apr; 58(1):162-9. PubMed ID: 12667958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
    Feldman AL; Tamarkin L; Paciotti GF; Simpson BW; Linehan WM; Yang JC; Fogler WE; Turner EM; Alexander HR; Libutti SK
    Clin Cancer Res; 2000 Dec; 6(12):4628-34. PubMed ID: 11156212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor serum levels in pregnancy and preeclampsia.
    Hefler L; Obermair A; Husslein P; Kainz C; Tempfer C
    Acta Obstet Gynecol Scand; 2000 Jan; 79(1):77-8. PubMed ID: 10646821
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia.
    Trollmann R; Amann K; Schoof E; Beinder E; Wenzel D; Rascher W; Dötsch J
    Am J Obstet Gynecol; 2003 Feb; 188(2):517-23. PubMed ID: 12592265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    McGirt MJ; Lynch JR; Blessing R; Warner DS; Friedman AH; Laskowitz DT
    Neurosurgery; 2002 Nov; 51(5):1128-34; discussion 1134-5. PubMed ID: 12383357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pitfalls in the measurement of circulating vascular endothelial growth factor.
    Jelkmann W
    Clin Chem; 2001 Apr; 47(4):617-23. PubMed ID: 11274009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation of circulating autoantibodies against VEGF-A, VEGFR-1 and PlGF in preeclampsia - A role in placental and vascular health?
    Moe K; Heidecke H; Dechend R; Staff AC
    Pregnancy Hypertens; 2017 Oct; 10():83-89. PubMed ID: 29153696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on association of vascular endothelial growth factor with the pathogenesis of pregnancy induced hypertension].
    Cheng Z; Lin Q; Shen Z
    Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):72-5. PubMed ID: 11783349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia.
    Cooper JC; Sharkey AM; Charnock-Jones DS; Palmer CR; Smith SK
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1191-6. PubMed ID: 8968234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The placental vascular endothelial growth factor polymorphisms and preeclampsia/preeclampsia severity.
    Keshavarzi F; Mohammadpour-Gharehbagh A; Shahrakipour M; Teimoori B; Yazdi A; Yaghmaei M; Naroeei-Nejad M; Salimi S
    Clin Exp Hypertens; 2017; 39(7):606-611. PubMed ID: 28665739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome.
    Webb NJ; Watson CJ; Roberts IS; Bottomley MJ; Jones CA; Lewis MA; Postlethwaite RJ; Brenchley PE
    Kidney Int; 1999 Mar; 55(3):1063-71. PubMed ID: 10027945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.